New Opioid Designed Multiple Ligand from Dmt-Tic and Morphinan Pharmacophores
摘要:
Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.
New Opioid Designed Multiple Ligand from Dmt-Tic and Morphinan Pharmacophores
摘要:
Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.
New Opioid Designed Multiple Ligand from Dmt-Tic and Morphinan Pharmacophores
作者:John L. Neumeyer、Xuemei Peng、Brian I. Knapp、Jean M. Bidlack、Lawrence H. Lazarus、Severo Salvadori、Claudio Trapella、Gianfranco Balboni
DOI:10.1021/jm0605785
日期:2006.9.1
Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.